-
Signature
-
/s/ Rose Neale, as attorney-in-fact for John Gyurci
-
Issuer symbol
-
SNCY
-
Transactions as of
-
29 Jan 2025
-
Net transactions value
-
-$48,684
-
Form type
-
4
-
Filing time
-
31 Jan 2025, 13:51:09 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
SNCY |
Common Stock, par value $0.01 per share |
Options Exercise |
$1,060 |
+200 |
+1.7% |
$5.30 |
11,818 |
29 Jan 2025 |
Direct |
|
| transaction |
SNCY |
Common Stock, par value $0.01 per share |
Sale |
$3,400 |
-200 |
-1.7% |
$17.00 |
11,618 |
29 Jan 2025 |
Direct |
F1 |
| transaction |
SNCY |
Common Stock, par value $0.01 per share |
Options Exercise |
$20,946 |
+3,952 |
+34% |
$5.30 |
15,570 |
30 Jan 2025 |
Direct |
|
| transaction |
SNCY |
Common Stock, par value $0.01 per share |
Sale |
$67,290 |
-3,952 |
-25% |
$17.03 |
11,618 |
30 Jan 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
SNCY |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-200 |
-0.37% |
$0.000000 |
53,683 |
29 Jan 2025 |
Common Stock |
200 |
$5.30 |
Direct |
F3 |
| transaction |
SNCY |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-3,952 |
-7.4% |
$0.000000 |
49,731 |
30 Jan 2025 |
Common Stock |
3,952 |
$5.30 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: